Propel Bio Management, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$100.7B
Holdings
21
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PAGPPLAINS GP HOLDINGS LP-CL | 1,272,360 | $23.4B | 23.23% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS | 43,032 | $13.3B | 13.19% | |
| 3 | AKROAKERO THERAPEUTICS INC | 343,729 | $9.6B | 9.50% | |
| 4 | SP4PACHIEVE LIFE SCIENCES INC | 2,453,092 | $8.6B | 8.58% | |
| 5 | APLTAPPLIED THERAPEUTICS INC | 9,615,420 | $8.2B | 8.18% | |
| 6 | PHATPHATHOM PHARMACEUTICALS I | 989,927 | $8.0B | 7.98% | |
| 7 | TCRXTSCAN THERAPEUTICS INC | 2,087,139 | $6.3B | 6.30% | |
| 8 | RNAAVIDITY BIOSCIENCES INC | 178,500 | $5.2B | 5.16% | |
| 9 | ARDXARDELYX INC | 950,947 | $4.8B | 4.79% | |
| 10 | ABEOABEONA THERAPEUTICS INC | 624,022 | $3.5B | 3.45% | |
| 11 | SNDXSYNDAX PHARMACEUTICALS IN | 183,259 | $2.4B | 2.41% | |
| 12 | KYMRKYMERA THERAPEUTICS INC | 56,359 | $2.3B | 2.25% | |
| 13 | ZVRAZEVRA THERAPEUTICS INC | 179,874 | $1.5B | 1.49% | |
| 14 | KURAKURA ONCOLOGY INC | 130,000 | $1.1B | 1.12% | |
| 15 | —ATHIRA PHARMA INC | 1,492,792 | $875.8M | 0.87% | |
| 16 | 72CEIGER BIOPHARMACEUTICALS | 146,381 | $765.0M | 0.76% | |
| 17 | JSPRJASPER THERAPEUTICS INC | 20,000 | $427.6M | 0.42% | |
| 18 | DCTHDELCATH SYSTEMS INC | 17,000 | $204.7M | 0.20% | |
| 19 | CMPSCOMPASS PATHWAYS PLC | 25,209 | $95.3M | 0.09% | |
| 20 | —MAAT PHARMA SACA | 3,151 | $25.1M | 0.02% | |
| 21 | —CHINOOK THERAPEUTICS | 79,357 | $9.8M | 0.01% |